Navigation Links
Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
Date:5/14/2009

al. "Clinical Course of Patients with Non -Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib." Clin. Cancer Res, 12, 839-844(2006). Available at: http://clincancerres.aacrjournals.org/cgi/reprint/12/3/839. Accessed on 5 May 2009.
  • Balak, M. N. et al. "Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors." Clin. Cancer Res. 12, 6494-6500 (2006). Available at: http://clincancerres.aacrjournals.org/cgi/reprint/12/21/6494. Accessed on 5 May 2009.
  • Ledermann, J. A. "A randomised Phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 followign treatment of relapsed ovarian cancer (OC)." Oral presentation, Clinical Science Symposium. Monday, 1 June 2009, Session Time 9:45AM - 11:15AM. # 5501
  • Hilberg F. et al. "BIBF1120 a novel, small molecule triple angiokinase inhibitor: profiling as a clinical candidate for cancer therapy." European Journal of Cancer Supplements. 2004; 2:50.
  • Lewis J. Kleinsmith. "Understanding Cancer and Related Topics: Understanding Angiogenesis." Rockville: National Cancer Institute, 2006. Available at: http://cancer.gov/cancertopics/understandingcancer. Accessed on 5 May 2009.
  • P Bo
    '/>"/>

  • SOURCE Boehringer Ingelheim
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
    2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
    3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
    5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
    8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
    9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
    10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
    11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/6/2015)... Inc. (Nasdaq: NXTM ), a leading manufacturer of ... that exceed the top end of its guidance range. ... 2015 increased 10 percent to $79.5 million, compared with ... 2014. The Company,s revenue guidance range for the first ... was driven by outperformance in the System One segment ...
    (Date:5/6/2015)... Eli Lilly and Company (NYSE: LLY ... delivery and device innovation center in Cambridge, ... help attract top scientists and bioengineers, as well as ... The Lilly Cambridge Innovation Center, a makerspace located in ... organizations to explore how emerging technologies and connectivity can ...
    (Date:5/6/2015)... 2015 According to a ... Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, ... Kits, Reagents, Resins) by Application & End User ...  the global Protein Purification and Isolation Market was ... is expected to reach $ 6,370 Million by ...
    Breaking Medicine Technology:NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 2NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 3NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 4NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 5NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 6NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 7NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 8NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 9NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 10NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 11Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 2Protein Purification and Isolation Market Worth $6,370 Million by 2020 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 4
    ... LAKES, N.J. and MONTREAL, Oct. 13, 2011 A ... gene testing analysis found that 38 percent of patients ... clots, heart attack and stroke—were also using another drug ... http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO ) The analysis also showed that ...
    ... (NYSE AMEX: ULU ), announced today that it has ... company based in Switzerland, to license Altrazeal® for the European Union. ... the European Union rights to a subsidiary of Melmed Holdings AG ... for the license ULURU will receive a licensing payment and a ...
    Cached Medicine Technology:Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4ULURU Inc. Announces Altrazeal® Agreement for the European Market 2ULURU Inc. Announces Altrazeal® Agreement for the European Market 3
    (Date:5/6/2015)... 06, 2015 Established by the Arthritis ... the estimated 46 million Americans who suffer from arthritis. ... medications to alleviate their symptoms. Medicationdiscountcard.com is proud to ... patients money on the costs of these necessary prescriptions. ... to treat the pain and inflammation in the joints ...
    (Date:5/6/2015)... 06, 2015 The Jefferson Awards ... to activating and celebrating public service, announced today ... Health, as an Outstanding Employee Volunteer Organization. Champions ... Awards Foundation, are dedicated to building a culture ... decade, Highmark Health has recognized employees who volunteer ...
    (Date:5/6/2015)... Stout Industries is owned and operated by ... Texas fire departments. Stout Industries recently developed Fire-ground Injury ... to these fire safety devices. The departure lights are ... turned on. They light the area within 50 feet of ... the roof, preventing leg and ankle injuries. In 2013 ...
    (Date:5/6/2015)... NH (PRWEB) May 06, 2015 Launch Corporation, ... has opened its new Nashua location at 17 Tanguay Avenue. ... will be the duo’s second Launch location in New England. ... their new team,” said Rob Arnold, founder, co-owner and CEO ... location and we look forward to seeing them continue to ...
    (Date:5/6/2015)... (PRWEB) May 06, 2015 The SGNY ... New York City, announced today that it was named ... for a presentation video produced on behalf of Intarcia ... the category of motion graphics. , The competition sponsored ... received over 6000 entries from 22 countries. The ...
    Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4Health News:Kickstarter for FIRE Lights, the New Fire Safety Devices 2Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2
    ... 23 Niutang Chemical, a leading,global manufacturer of ... Alan Turner to lead its new office in ... Ltd., Mr. Turner will,spearhead all of Nuitang,s sales ... acid. He will particularly focus on the company,s,fast-growing ...
    ... WellPoint, Inc. (NYSE:,WLP) today announced the appointment ... segment, effective July 8, 2008., In his ... WellPoint,s,Individual Business segment, which currently serves more than ... add the quality of experience and,strategic expertise that ...
    ... individuals had more advanced disease and were less likely ... News) -- Low socioeconomic status increases a cancer patient,s ... on almost 14,000 breast, prostate and colorectal patients in ... patients with low socioeconomic status had more advanced cancers ...
    ... discovery holds promise as a treatment target for this diverse ... Cancerous myeloma cells are so "addicted" to a gene known ... has revealed. , Reducing the activity of the gene by ... compromising other healthy activities, said scientists reporting in the current ...
    ... AFAM ) announced today that it is scheduled to ... of market on June 27,according to a preliminary list of ... B. Yarmuth, President and CEO of Almost Family, Inc., stated,"We ... end of June as,it will provide greater awareness and visibility ...
    ... Before Disaster ... Fans, Players and Coaches, CLEVELAND, June 23 The ... -- able to,detect hidden flaws or developed stress within Major ... -- will be introduced as,BatteryMate(TM) on June 27, 2008, at ...
    Cached Medicine News:Health News:Niutang Recruits Seasoned Executive to Open U.K. Office 2Health News:WellPoint Appoints Raj G. Bal as President of Individual Business 2Health News:Poorer Patients Have Poorer Survival After Cancer Diagnosis 2Health News:One Gene May Be Key to Myeloma 2Health News:One Gene May Be Key to Myeloma 3Health News:Almost Family, Inc. Set to Join to Russell 2000(R) Index 2Health News:Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats 2Health News:Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats 3
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: